Novartis AG is 101.6x more valuable than Arcus Biosciences, Inc. by market capitalization ($282.64 B vs $2.78 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | RCUS | NVS |
|---|---|---|
| Market cap | $2.78 B | $282.64 B |
| US-listed rank | #1869 | #47 |
| Revenue (latest FY) | $247.00M | - |
| Net income (latest FY) | -$353.00M | - |
| Net margin | -142.9% | - |
| SEC filings | 567 | 947 |
Novartis AG is 101.6x more valuable than Arcus Biosciences, Inc. by market capitalization ($282.64 B vs $2.78 B).
Full pages: Arcus Biosciences, Inc. and Novartis AG, or browse the full rankings.